Hepatic-stellate-cell-targeted delivery of PU.1 decoy ODN by Apt-Tan attenuates liver fibrosis in mice
Targeted therapeutics for liver fibrosis (LF) are unavailable. PU.1 is a pioneer transcription factor (TF) that promotes hepatic stellate cell (HSC) activation and LF. PU.1 decoy oligodeoxynucleotides (ODNs) can potentially repress LF by capturing PU.1. In this study, we used Apt-Tan, a hepatic stel...
Saved in:
| Main Authors: | Yong Tan, Li-Ye Zhang, Yue Sun, Xiao-Jie Luo, Si-Yuan Wu, Xian-Zhi Wu, Yan-Qiong Zhang, Ying Wang, Bo-Tao Li, Yi-Ran Ni, Lan Ma, Jiang-Feng Wu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | Molecular Therapy: Nucleic Acids |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253125001611 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advantages, applications, and future directions of in vivo aptamer SELEX: A review
by: Minchuan Lyu, et al.
Published: (2025-09-01) -
Aptamer–ODN Chimeras: Enabling Cell-Specific ODN Targeting Therapy
by: Bei Xia, et al.
Published: (2025-05-01) -
DeepAptamer: Advancing high-affinity aptamer discovery with a hybrid deep learning model
by: Xin Yang, et al.
Published: (2025-03-01) -
DNA aptamer AptERA 2 targets ERA from Staphylococcus aureus and limits GTP hydrolysis
by: Katherin Peñaranda, et al.
Published: (2025-08-01) -
Combined treatment using bismuth sulfide nanoparticles loaded with NANOG decoy oligodeoxynucleotides under X-ray radiation for breast cancer cells
by: Sara Heidari, et al.
Published: (2025-07-01)